CAROLINE MOSER: Open Payments
NPI 1518646397 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,495 in 110 payments from 17 companies in 2025. Trend: 2023 $113 · 2024 $1,886 · 2025 $2,495
Food & beverage: $2,413Education: $83
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 11 | $374 |
| ABBVIE INC. | 12 | $360 |
| Janssen Scientific Affairs, LLC | 4 | $358 |
| Verrica Pharmaceuticals Inc. | 41 | $355 |
| Janssen Biotech, Inc. | 13 | $274 |
| GENZYME CORPORATION | 6 | $144 |
| E.R. Squibb & Sons, L.L.C. | 2 | $142 |
| Amgen Inc. | 2 | $107 |
| UCB, Inc. | 4 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
Products named: TREMFYA, OPZELURA, YCANTH, SKYRIZI, DUPIXENT, Sotyktu, Bimzelx, COSENTYX.
Industry payments across CA — which companies pay providers there.
